kpNext(TM) Klöckner Pentaplast Launches Its New Recylable Pet Blister Film
SUZHOU, China, Oct. 18, 2021 /PRNewswire/ -- Klöckner Pentaplast (kp), a leading global manufacturer of high barrier protective packaging solutions with industry-leading use of recycled content material, has launched kpNext™, its first-to-market innovation in recyclable PET blister films. kpNext is the only PET recyclable blister that is completely compatible on pharmaceutical manufacturing form, fill and seal equipment. kpNext(TM) NEW RECYLABLE PET...
NeuExcell Therapeutics names Lori Gavrin as Chief Business and Strategy Officer
STATE COLLEGE, Penn., Oct. 18, 2021 /PRNewswire/ -- NeuExcell Therapeutics Inc. (www.neuexcell.com) today announced the appointment of Lori Gavrin, Ph.D. to the new position of Chief Business and Strategy Officer, effective immediately. Dr. Gavrin will report directly to Dr. Ronald HW Lorijn, Chief Executive Officer, and will lead and manage the strategic...
Concord Medical Is Shortlisted for the “5G+Healthcare” Pilot Project
BEIJING, Oct. 18, 2021 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and diagnostic imaging centers in China, today announced that two projects of it, Jiahe Cloud Imaging Remote Medical...
Artificial Intelligence to Boost the Global Wound Care Market by 2026 with Minimal Intervention Solutions
The global wound care solutions market is estimated to garner $30.5 billion in revenue by 2026 at a compound annual growth rate of 6.7%, finds Frost & Sullivan SAN ANTONIO, Oct. 18, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis, Global Wound Care Solutions and New-age Technology Growth Opportunities, finds that participants in the wound care industry are investing heavily...
Mentice receives order of total SEK 7.0 million from ABBOTT
STOCKHOLM, Oct. 18, 2021 /PRNewswire/ -- Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, has through its fully owned subsidiary Mentice Inc entered into an agreement with ABBOTT Inc. to provide simulation solutions for training of interventional devices. The order covers systems that will be offered under...
Nanoform convenes EGM to elect Jeanne Thoma as board member
HELSINKI, Finland, Oct. 18, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, will convene an extraordinary general meeting (EGM) on November 17, 2021, at 14:00 EEST to elect Jeanne Thoma as a new board member. The notice to the EGM was published simultaneously with this company announcement. Jeanne Thoma, a renowned global executive in...
2021 Hengshui Lake Marathon & National Marathon Championships (Hengshui Station) kicks off
HENGSHUI, China, Oct. 18, 2021 /PRNewswire/ -- The "Bank of Hengshui Cup" 2021 Hengshui Lake Marathon & National Marathon Championships (Hengshui Station) kicked off at Hengshui Lake Marathon Square at 7:30 AM on October 17 with some 20,000 runners from around the country participating in the event. The grace displayed by the athletes as they began their run set against...
WuXi ATU Opens New Manufacturing Facility to Further Enhance Its CTDMO Services for Global Customers
PHILADELPHIA, Oct. 18, 2021 /PRNewswire/ -- WuXi Advanced Therapies Inc. (WuXi ATU) – a wholly owned subsidiary of WuXi AppTec – today announced the opening of its new process development and commercial manufacturing facility in Lin-gang, Shanghai. WuXi ATU is a leading Contract, Testing, Development and Manufacturing Organization (CTDMO) headquartered in Philadelphia. As its fourth manufacturing site worldwide, the new...
Alphamab Oncology Completed Enrollment in the First Pivotal Phase III Clinical Study of the Bispecific Antibody KN046
ENREACH-LUNG-01 is a multi-center, randomized, double-blind, placebo-controlled phase III clinical study of KN046 combined with platinum-containing chemotherapy in patients with advanced unresectable or metastatic squamous NSCLC. Enrollment of all 482 patients has been completed according to the study design in 61 clinical research centers nationwide. SUZHOU, China, Oct. 18, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK), announced...
OSIM enters into virtual reality with the #uDreamOutOfThisWorld campaign featuring its first virtual ambassador Rae
SINGAPORE, Oct. 18, 2021 /PRNewswire/ -- From the home-grown wellness brand that is synonymous with revolutionary massage innovations headlined by Asia's top celebrities, OSIM is thrilled to welcome virtual personality Rae — its first — as the ambassador for the #uDreamOutOfThisWorld campaign, promoting the world's first 5-senses well-being chair now upgraded to uDream Pro. A Singapore-born virtual being with...
